Policy Advocacy & Stakeholder engagement

Policy crafted to
unlock markets

Developing targeted policy positions and advocacy strategies that remove systemic barriers and secure durable patient access.

Engineering stakeholder consensus for decision certainty

We combine position papers, local stakeholder mapping and calibrated engagement to build consensus across markets.

Instruments for influence
and alignment

Position papers & policy support

We author evidence-driven position papers, policy briefs and technical annexes that articulate public health, societal, clinical and economic arguments for clinical and policy decision makers.

Stakeholder mapping & engagement

We map influence networks, prioritise stakeholders and execute targeted engagement plans to align policy makers, payers, clinicians and regulators with evidence-based policy objectives.

Explore our
Value & Access Suite

Strategic Market Assessment & Planning

We conduct comprehensive landscape analyses to help you identify market opportunities, inform early access strategies and guide launch sequencing.

Product Value & Pricing Strategy

We develop and test Target Product Profiles (TPP), assess willingness-to-pay and craft compelling value propositions to support your market positioning.

Evidence & HTA Support

We design integrated evidence plans and provide HTA submission support to demonstrate your product value to payers.

Negotiation & Access Agreements

We formulate tender & managed entry strategies and support negotiations to secure favourable pricing & access for your assets.

Insights designed
for execution

Know More

Navigating the UAE’s Regulatory Shift: From Ambition to

The Future of Biopharma: China and Saudi Arabia are redefining “Pharmerging”

Strategic Defense against Generic Entry for Rare Disease Products in KSA

Let's talk

Whether you're expanding into the region or rethinking your local strategy, we're here to help.